Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial

Daylight Photodynamic Therapy in Private Practice in Switzerland: Gain Without Pain

(2013) L Braathen   ACTA DERMATO-VENEREOLOGICA

Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study

(2012) S.R. Wiegell et al.   BRITISH JOURNAL OF DERMATOLOGY

European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen’s disease, basal cell carcinoma

(2012) C.A. Morton et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp

(2011) S.R. Wiegell et al.   BRITISH JOURNAL OF DERMATOLOGY

Daylight photodynamic therapy for actinic keratosis: an international consensus

(2011) S.R. Wiegell et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial

(2009) S.R. Wiegell et al.   BRITISH JOURNAL OF DERMATOLOGY

Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study

(2008) S.R. Wiegell et al.   BRITISH JOURNAL OF DERMATOLOGY